Soleno Therapeutics SLNO Stock
Soleno Therapeutics Price Chart
Soleno Therapeutics SLNO Financial and Trading Overview
| Soleno Therapeutics stock price | 53.01 USD |
| Previous Close | 0 USD |
| Open | 52.98 USD |
| Bid | 38.15 USD x 200 |
| Ask | 67.82 USD x 200 |
| Day's Range | 52.98 - 53.01 USD |
| 52 Week Range | 29.43 - 90.32 USD |
| Volume | 4.97M USD |
| Avg. Volume | 3.62M USD |
| Market Cap | 2.76B USD |
| Beta (5Y Monthly) | -2.217 |
| PE Ratio (TTM) | 27.466322 |
| EPS (TTM) | 1.93 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 53 USD |
SLNO Valuation Measures
| Enterprise Value | 2.56B USD |
| Trailing P/E | 27.466322 |
| Forward P/E | -23.352423 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.694076 |
| Price/Book (mrq) | 6.1575093 |
| Enterprise Value/Revenue | 8.988 |
| Enterprise Value/EBITDA | 27.991 |
Trading Information
Soleno Therapeutics Stock Price History
| Beta (5Y Monthly) | -2.217 |
| 52-Week Change | -30.48% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 90.32 USD |
| 52 Week Low | 29.43 USD |
| 50-Day Moving Average | 45.78 USD |
| 200-Day Moving Average | 51.16 USD |
SLNO Share Statistics
| Avg. Volume (3 month) | 3.62M USD |
| Avg. Daily Volume (10-Days) | 1.8M USD |
| Shares Outstanding | 52.12M |
| Float | 51.46M |
| Short Ratio | 1.01 |
| % Held by Insiders | 1.31% |
| % Held by Institutions | 111.52% |
| Shares Short | 6.53M |
| Short % of Float | 17.88% |
| Short % of Shares Outstanding | 12.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 33.69% |
| Operating Margin (ttm) | 33.57% |
| Gross Margin | 98.63% |
| EBITDA Margin | 32.10% |
Management Effectiveness
| Return on Assets (ttm) | 12.07% |
| Return on Equity (ttm) | 26.38% |
Income Statement
| Revenue (ttm) | 285.01M USD |
| Revenue Per Share (ttm) | 5.45 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 281.11M USD |
| EBITDA | 91.52M USD |
| Net Income Avi to Common (ttm) | 95.63M USD |
| Diluted EPS (ttm) | 1.93 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 255.6M USD |
| Total Cash Per Share (mrq) | 4.9 USD |
| Total Debt (mrq) | 54.28M USD |
| Total Debt/Equity (mrq) | 10.95 USD |
| Current Ratio (mrq) | 5.622 |
| Book Value Per Share (mrq) | 8.609 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 105.53M USD |
| Levered Free Cash Flow (ttm) | 91.67M USD |
Profile of Soleno Therapeutics
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 100 Marine Parkway |
| ZIP | 94065 |
| Phone | 650 213 8444 |
| Website | https://soleno.life |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 182 |
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. As of May 18, 2026, Soleno Therapeutics, Inc. operates as a subsidiary of Neurocrine Biosciences, Inc.
Q&A For Soleno Therapeutics Stock
What is a current SLNO stock price?
Soleno Therapeutics SLNO stock price today per share is 53.01 USD.
How to purchase Soleno Therapeutics stock?
You can buy SLNO shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Soleno Therapeutics?
The stock symbol or ticker of Soleno Therapeutics is SLNO.
Which industry does the Soleno Therapeutics company belong to?
The Soleno Therapeutics industry is Biotechnology.
How many shares does Soleno Therapeutics have in circulation?
The max supply of Soleno Therapeutics shares is 52.12M.
What is Soleno Therapeutics Price to Earnings Ratio (PE Ratio)?
Soleno Therapeutics PE Ratio is 27.46632200 now.
What was Soleno Therapeutics earnings per share over the trailing 12 months (TTM)?
Soleno Therapeutics EPS is 1.93 USD over the trailing 12 months.
Which sector does the Soleno Therapeutics company belong to?
The Soleno Therapeutics sector is Healthcare.
Soleno Therapeutics SLNO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
146.53 USD — |
-0.75
|
— — | 144.14 USD — | 148.72 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}